EULAR Presentation Showed Upadacitinib Improved Lupus Disease Activity News Update May 31, 2023 We are pleased to share encouraging news from EULAR, the annual meeting of the European Alliance of...
Rinvoq Advances to Phase 3 in Lupus News Update March 27, 2023 Based on positive results of a Phase 2 clinical trial testing upadacitinib (Rinvoq®) given alone or with...
